| abstract |
The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata ( L. operculata ), S. officinale ( V. sabadilla ), and Galphimia Glauca ( G. glauca ) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata ( L. operculata ) 10% extract MT, S. officinale ( V. sabadilla ) 3× extract, and Galphimia Glauca ( G. glauca ) 10% extract MT in a pharmaceutically acceptable carrier. |